- Home
- AHH vs RLAY Comparison
AHH vs RLAY Comparison
Compare AHH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHH
- RLAY
- Stock Information
- Founded
- AHH 1979
- RLAY 2015
- Country
- AHH United States
- RLAY United States
- Employees
- AHH N/A
- RLAY N/A
- Industry
- AHH Real Estate
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AHH Finance
- RLAY Health Care
- Exchange
- AHH Nasdaq
- RLAY Nasdaq
- Market Cap
- AHH 557.1M
- RLAY 610.3M
- IPO Year
- AHH 2013
- RLAY 2020
- Fundamental
- Price
- AHH $7.25
- RLAY $3.59
- Analyst Decision
- AHH Buy
- RLAY Strong Buy
- Analyst Count
- AHH 4
- RLAY 12
- Target Price
- AHH $8.38
- RLAY $18.27
- AVG Volume (30 Days)
- AHH 627.7K
- RLAY 1.4M
- Earning Date
- AHH 08-04-2025
- RLAY 08-07-2025
- Dividend Yield
- AHH 11.27%
- RLAY N/A
- EPS Growth
- AHH N/A
- RLAY N/A
- EPS
- AHH 0.13
- RLAY N/A
- Revenue
- AHH $544,168,000.00
- RLAY $8,355,000.00
- Revenue This Year
- AHH N/A
- RLAY $31.55
- Revenue Next Year
- AHH $4.50
- RLAY N/A
- P/E Ratio
- AHH $56.19
- RLAY N/A
- Revenue Growth
- AHH N/A
- RLAY N/A
- 52 Week Low
- AHH $6.10
- RLAY $1.78
- 52 Week High
- AHH $12.33
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- AHH 59.44
- RLAY 53.10
- Support Level
- AHH $7.01
- RLAY $3.45
- Resistance Level
- AHH $7.28
- RLAY $3.72
- Average True Range (ATR)
- AHH 0.14
- RLAY 0.16
- MACD
- AHH 0.03
- RLAY 0.02
- Stochastic Oscillator
- AHH 90.00
- RLAY 70.00
About AHH Armada Hoffler Properties Inc.
Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).